Meeting
2024 ASCO Gastrointestinal Cancers Symposium
The efficacy of adjuvant chemotherapy after total mesorectal excision with selective lateral pelvic node dissection for lower rectal cancer.
Authors
Shin Kameishi
Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
Shin Kameishi , Toshifumi Yamaguchi , Hiroki Hamamoto , Dai Okemoto , Toru Kadono , Hiroki Yukami , Masahiro Goto , Hiroki Nishikawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 50)
DOI
10.1200/JCO.2024.42.3_suppl.50
Abstract #
50
Poster Bd #
D13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The efficacy of chemotherapy for colorectal cancer with early recurrence after adjuvant chemotherapy.
First Author: Dai Okemoto
Poster
2022 ASCO Annual Meeting
Effect of adjuvant chemotherapy in patients with stage III colon cancer based on the Multi-Institutional Registry of Large Bowel Cancer in Japan.
First Author: Yasuhide Yamada
Poster
2016 Gastrointestinal Cancers Symposium
“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
First Author: Jy Ming Chiang
Poster
2024 ASCO Annual Meeting
Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.
First Author: Alberto Puccini